title: Chiral separation of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling and its effects on oxidative stress status in rat liver.
abstract: This work reports the multimiligram separation of 3,4-methylenedioxy-methamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling. The effect of both enantiomers compared to the racemic mixture was examined on the oxidative stress status of rat liver. The enantiomeric purification was performed using a based cyclodextrin chiral selector and methanol:ammonium acetate buffer (pH 6.0, 100mM) (30:70, v/v) as mobile phase. The average mass rate obtained was 40.0mg/day, providing 45.0mg of the (R)-(-)-MDMA (e.r. 99.0%) and 75.0mg (e.r. 96.0%) of (S)-(+)-MDMA. Racemic MDMA and both enantiomers were administered per orally to Wistar rats and oxidative stress status parameters, as liver total glutathione levels and malondialdehyde (MDA) production in liver were evaluated. There was a significant decrease in hepatic glutathione content in the racemic MDMA and the (R)-(-)-MDMA-treated rats when compared to the control and to (S)-(+)-MDMA. These results demonstrate that the R-enantiomer is the enantiomer that contributes to the depletion of hepatic glutathione induced by the racemic mixture. The high reactivity of the R-enantiomer of MDMA in the liver can also be observed in animals treated with (R)-(-)-MDMA. The production of malondialdehyde (MDA) by (R)-(-)-MDMA was significantly higher when compared to the other treated groups and control.
authors.affiliation: Departamento de Química, Universidade Federal de São Carlos, São Carlos - SP, Brazil.
authors.forename: Tiago C
authors.initials: TC
authors.lastname: Lourenço
authors.forename: Graziela C
authors.initials: GC
authors.lastname: Bósio
authors.forename: Neila M
authors.initials: NM
authors.lastname: Cassiano
authors.forename: Quezia B
authors.initials: QB
authors.lastname: Cass
authors.forename: Regina L M
authors.initials: RL
authors.lastname: Moreau
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D005978:Glutathione / Q000378:metabolism; D057166:High-Throughput Screening Assays; D013287:Illicit Drugs / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D013237:Stereoisomerism
chemical_list: D013287:Illicit Drugs; D008315:Malondialdehyde; D005978:Glutathione; D018817:N-Methyl-3,4-methylenedioxyamphetamine